UTI files Form 144 to sell 3.97M shares

UTI filed a Form 144 reporting a proposed sale of 3,971,440 shares of Common Stock.

Rhea-AI Filing Summary

UTI filed a Form 144 reporting a proposed sale of 3,971,440 shares of Common Stock. The filing lists an aggregate amount of $173,035,640.80 and names Morgan Stanley & Co. LLC as broker. The securities are to be sold on the NYSE with a sale-related date of 06/08/2026. The filing states the shares were acquired by purchases directly from Issuer and open market purchases with an acquisition date shown as 06/24/2016.

Insights

Securities Lawyer

Form 144 is a routine affiliate notice for proposed resale of shares.

Form 144 reports a proposed sale of 3,971,440 shares through Morgan Stanley & Co. LLC on the NYSE. The filing provides an aggregate dollar figure and acquisition method; it does not itself effect a sale.

Timing and price execution depend on broker activity and market conditions; subsequent filings will disclose whether the resale occurred and any shares actually sold.

Key Figures

Shares proposed for resale: 3,971,440 shares Aggregate amount listed: $173,035,640.80 Sale-related date: 06/08/2026 +1 more

4 metrics

Shares proposed for resale 3,971,440 shares Filed on Form 144 for Common Stock

Aggregate amount listed $173,035,640.80 Aggregate figure on Form 144 line associated with the shares

Sale-related date 06/08/2026 Date shown on the Form 144 entry

Acquisition date shown 06/24/2016 Acquisition method listed as purchases directly from Issuer and open market

Key Terms

Form 144, Open Market Purchases, Aggregate amount

3 terms

Form 144 regulatory

"Filed to report proposed resale of restricted or affiliate-held securities"

Form 144 is a document that investors must file with the government when they plan to sell a large number of shares of a company's stock. It helps ensure transparency so everyone knows how many shares are being sold and when, which can impact the stock's price.

Open Market Purchases market

"Acquisition method listed as purchases directly from Issuer and Open Market Purchases"

Open market purchases are buys of a company’s shares (or other securities) made on public exchanges at prevailing market prices rather than through private deals. For investors this matters because when a company buys back its own stock it reduces the number of shares available, which can boost per-share earnings and often signals management’s confidence; it also affects supply, demand and short-term liquidity much like someone quietly buying up items from a crowded marketplace.

Aggregate amount financial

"Line showing 173035640.80 associated with the proposed resale"

FAQ

AI-generated questions and answers. How Rhea-AI works. Not financial advice.

What does UTI's Form 144 disclose?

The Form 144 discloses a proposed resale of 3,971,440 shares of Common Stock and an aggregate value of $173,035,640.80. It names Morgan Stanley & Co. LLC as the broker and lists the NYSE as the market.

Who is the broker handling the proposed sale in UTI's Form 144?

The filing lists Morgan Stanley & Co. LLC as the broker. The broker is the intermediary identified for effecting the proposed resale on the NYSE according to the form's fields.

When were the shares in UTI's Form 144 acquired?

The Form 144 shows acquisition by purchases directly from the issuer and open market purchases with an acquisition date of 06/24/2016. That acquisition detail appears on the form's transaction lines.

Does Form 144 mean the shares have already been sold?

No. Form 144 notifies the SEC of a proposed resale by an affiliate; it does not confirm completion. Actual sale execution and quantities sold must be reported separately if and when the transactions occur.

Which exchange is identified for the proposed resale in UTI's Form 144?

The filing identifies the NYSE as the exchange for the proposed resale and includes a date field of 06/08/2026 associated with the sale-related entry on the form.

AI-generated analysis. How Rhea-AI works. Not financial advice.

See more from StockTitan in Google Search and AI answers. Adds StockTitan as a preferred source · opens Google

Add on Google Not now

Accepted by SEC EDGAR 06/08/2026 - 06:42 PM Learn about SEC filing dates

Form 144 Filer Information	UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 Form 144 NOTICE OF PROPOSED SALE OF SECURITIES PURSUANT TO RULE 144 UNDER THE SECURITIES ACT OF 1933
FORM 144

144: Filer Information

Filer CIK	0001409751
Filer CCC	XXXXXXXX
Is this a LIVE or TEST Filing?	LIVE TEST
Submission Contact Information
Name
Phone
E-Mail Address

144: Issuer Information

Name of Issuer	UNIVERSAL TECHNICAL INSTITUTE, INC.
SEC File Number	001-31923
Address of Issuer	4225 East Windrose Drive, Suite 200 Phoenix ARIZONA 85032
Phone	(623)-445-9500
Name of Person for Whose Account the Securities are To Be Sold	Coliseum Capital Management, LLC
See the definition of "person" in paragraph (a) of Rule 144. Information is to be given not only as to the person for whose account the securities are to be sold but also as to all other persons included in that definition. In addition, information shall be given as to sales by all persons whose sales are required by paragraph (e) of Rule 144 to be aggregated with sales for the account of the person filing this notice.
Relationship to Issuer	Director

144: Securities Information

Title of the Class of Securities To Be Sold	Name and Address of the Broker	Number of Shares or Other Units To Be Sold	Aggregate Market Value	Number of Shares or Other Units Outstanding	Approximate Date of Sale	Name the Securities Exchange
Common Stock	Morgan Stanley & Co. LLC 1585 Broadway New York NY 10036	3971440	173035640.80	55061381	06/08/2026	NYSE

Furnish the following information with respect to the acquisition of the securities to be sold and with respect to the payment of all or any part of the purchase price or other consideration therefor:

144: Securities To Be Sold

Title of the Class	Date you Acquired	Nature of Acquisition Transaction	Name of Person from Whom Acquired	Is this a Gift?	Date Donor Acquired	Amount of Securities Acquired	Date of Payment	Nature of Payment *
Common Stock	06/24/2016	Purchases directly from Issuer and Open Market Purchases	Issuer and Open Market Purchases			3971440	06/24/2016	Cash

* If the securities were purchased and full payment therefor was not made in cash at the time of purchase, explain in the table or in a note thereto the nature of the consideration given. If the consideration consisted of any note or other obligation, or if payment was made in installments describe the arrangement and state when the note or other obligation was discharged in full or the last installment paid.

Furnish the following information as to all securities of the issuer sold during the past 3 months by the person for whose account the securities are to be sold.

144: Securities Sold During The Past 3 Months

Nothing to Report

144: Remarks and Signature

Remarks	The securities referred to in this Form 144 are held directly by (a) Coliseum Capital Partners, L.P., an investment limited partnership of which Coliseum Capital, LLC, a Delaware limited liability company ("CC"), is general partner and for which Coliseum Capital Management, LLC, a Delaware limited liability company ("CCM"), serves as investment adviser and (b) a separate account investment advisory client of CCM. Christopher Shackelton and Adam Gray are managers of and have an ownership interest in each of CCM and CC. Mr. Shackelton is a director of the Issuer. Regarding the "Securities To Be Sold" table, the dates of acquisition and the dates of payment varied (and included purchases of the Issuer's Series A Preferred Stock that converted into Common Stock), with purchases commencing on June 24, 2016.
Date of Notice	06/08/2026
ATTENTION:
The person for whose account the securities to which this notice relates are to be sold hereby represents by signing this notice that he does not know any material adverse information in regard to the current and prospective operations of the Issuer of the securities to be sold which has not been publicly disclosed. If such person has adopted a written trading plan or given trading instructions to satisfy Rule 10b5-1 under the Exchange Act, by signing the form and indicating the date that the plan was adopted or the instruction given, that person makes such representation as of the plan adoption or instruction date.
Signature	/s/ Chivonne Cassar, as Attorney-in-Fact
ATTENTION: Intentional misstatements or omission of facts constitute Federal Criminal Violations (See 18 U.S.C. 1001)